148 related articles for article (PubMed ID: 35068946)
1. Classification of bladder cancer cell lines according to regulon activity.
Eray A; Erkek-Özhan S
Turk J Biol; 2021; 45(6):656-666. PubMed ID: 35068946
[TBL] [Abstract][Full Text] [Related]
2. New horizons in bladder cancer research.
Boormans JL; Zwarthoff EC; Black PC; Goebell PJ; Kamat AM; Nawroth R; Seiler R; Williams SB; Schmitz-Dräger BJ
Urol Oncol; 2020 Dec; 38(12):867-885. PubMed ID: 30852032
[TBL] [Abstract][Full Text] [Related]
3. Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical Use.
Dadhania V; Zhang M; Zhang L; Bondaruk J; Majewski T; Siefker-Radtke A; Guo CC; Dinney C; Cogdell DE; Zhang S; Lee S; Lee JG; Weinstein JN; Baggerly K; McConkey D; Czerniak B
EBioMedicine; 2016 Oct; 12():105-117. PubMed ID: 27612592
[TBL] [Abstract][Full Text] [Related]
4. FOXA1, GATA3 and PPARɣ Cooperate to Drive Luminal Subtype in Bladder Cancer: A Molecular Analysis of Established Human Cell Lines.
Warrick JI; Walter V; Yamashita H; Chung E; Shuman L; Amponsa VO; Zheng Z; Chan W; Whitcomb TL; Yue F; Iyyanki T; Kawasawa YI; Kaag M; Guo W; Raman JD; Park JS; DeGraff DJ
Sci Rep; 2016 Dec; 6():38531. PubMed ID: 27924948
[TBL] [Abstract][Full Text] [Related]
5. Bladder Cancer Molecular Taxonomy: Summary from a Consensus Meeting.
Lerner SP; McConkey DJ; Hoadley KA; Chan KS; Kim WY; Radvanyi F; Höglund M; Real FX
Bladder Cancer; 2016 Jan; 2(1):37-47. PubMed ID: 27376123
[TBL] [Abstract][Full Text] [Related]
6. Molecular subtypes of urothelial carcinoma are defined by specific gene regulatory systems.
Eriksson P; Aine M; Veerla S; Liedberg F; Sjödahl G; Höglund M
BMC Med Genomics; 2015 May; 8():25. PubMed ID: 26008846
[TBL] [Abstract][Full Text] [Related]
7. Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic Implications.
Hovelson DH; Udager AM; McDaniel AS; Grivas P; Palmbos P; Tamura S; Lazo de la Vega L; Palapattu G; Veeneman B; El-Sawy L; Sadis SE; Morgan TM; Montgomery JS; Weizer AZ; Day KC; Neamati N; Liebert M; Keller ET; Day ML; Mehra R; Tomlins SA
Eur Urol; 2018 Dec; 74(6):741-753. PubMed ID: 30033047
[TBL] [Abstract][Full Text] [Related]
8. Hypermethylation of FOXA1 and allelic loss of PTEN drive squamous differentiation and promote heterogeneity in bladder cancer.
Osei-Amponsa V; Buckwalter JM; Shuman L; Zheng Z; Yamashita H; Walter V; Wildermuth T; Ellis-Mohl J; Liu C; Warrick JI; Shantz LM; Feehan RP; Al-Ahmadie H; Mendelsohn C; Raman JD; Kaestner KH; Wu XR; DeGraff DJ
Oncogene; 2020 Feb; 39(6):1302-1317. PubMed ID: 31636388
[TBL] [Abstract][Full Text] [Related]
9. A Consensus Molecular Classification of Muscle-invasive Bladder Cancer.
Kamoun A; de Reyniès A; Allory Y; Sjödahl G; Robertson AG; Seiler R; Hoadley KA; Groeneveld CS; Al-Ahmadie H; Choi W; Castro MAA; Fontugne J; Eriksson P; Mo Q; Kardos J; Zlotta A; Hartmann A; Dinney CP; Bellmunt J; Powles T; Malats N; Chan KS; Kim WY; McConkey DJ; Black PC; Dyrskjøt L; Höglund M; Lerner SP; Real FX; Radvanyi F;
Eur Urol; 2020 Apr; 77(4):420-433. PubMed ID: 31563503
[TBL] [Abstract][Full Text] [Related]
10. Analysis of open chromatin regions in bladder cancer links β-catenin mutations and Wnt signaling with neuronal subtype of bladder cancer.
Eray A; Güneri PY; Yılmaz GÖ; Karakülah G; Erkek-Ozhan S
Sci Rep; 2020 Oct; 10(1):18667. PubMed ID: 33122695
[TBL] [Abstract][Full Text] [Related]
11. Specific micro-RNA expression patterns distinguish the basal and luminal subtypes of muscle-invasive bladder cancer.
Ochoa AE; Choi W; Su X; Siefker-Radtke A; Czerniak B; Dinney C; McConkey DJ
Oncotarget; 2016 Dec; 7(49):80164-80174. PubMed ID: 27845906
[TBL] [Abstract][Full Text] [Related]
12. Molecular Classification of Bladder Urothelial Carcinoma Using NanoString-Based Gene Expression Analysis.
Lopez-Beltran A; Blanca A; Cimadamore A; Gogna R; Montironi R; Cheng L
Cancers (Basel); 2021 Nov; 13(21):. PubMed ID: 34771663
[TBL] [Abstract][Full Text] [Related]
13. Morphological correlation of urinary bladder cancer molecular subtypes in radical cystectomies.
Han L; Gallan AJ; Steinberg GD; Sweis RF; Paner GP
Hum Pathol; 2020 Dec; 106():54-61. PubMed ID: 32987034
[TBL] [Abstract][Full Text] [Related]
14. Pure high-grade papillary urothelial bladder cancer: a luminal-like subgroup with potential for targeted therapy.
Schnitzler T; Ortiz-Brüchle N; Schneider U; Lurje I; Guricova K; Buchner A; Schulz GB; Heidenreich A; Gaisa NT; Knüchel R; Garczyk S
Cell Oncol (Dordr); 2020 Oct; 43(5):807-819. PubMed ID: 32445084
[TBL] [Abstract][Full Text] [Related]
15. Update on bladder cancer molecular subtypes.
Fong MHY; Feng M; McConkey DJ; Choi W
Transl Androl Urol; 2020 Dec; 9(6):2881-2889. PubMed ID: 33457262
[TBL] [Abstract][Full Text] [Related]
16. Bladder cancer genomics.
Siracusano S; Rizzetto R; Porcaro AB
Urologia; 2020 May; 87(2):49-56. PubMed ID: 31942831
[TBL] [Abstract][Full Text] [Related]
17. Combined Mek inhibition and
Tate T; Plumber SA; Al-Ahmadie H; Chen X; Choi W; Lu C; Viny A; Batourina E; Gartensson K; Alija B; Molotkov A; Wiessner G; McKiernan J; McConkey D; Dinney C; Czerniak B; Mendelsohn CL
bioRxiv; 2023 Aug; ():. PubMed ID: 37662238
[TBL] [Abstract][Full Text] [Related]
18. Activation of PPARγ and inhibition of cell proliferation reduces key proteins associated with the basal subtype of bladder cancer in As3+-transformed UROtsa cells.
Mehus AA; Bergum N; Knutson P; Shrestha S; Zhou XD; Garrett SH; Sens DA; Sens MA; Somji S
PLoS One; 2020; 15(8):e0237976. PubMed ID: 32822399
[TBL] [Abstract][Full Text] [Related]
19. Analysis of bladder cancer subtypes in neurogenic bladder tumors.
Manach Q; Cussenot O; Rouprêt M; Gamé X; Chartier-Kastler E; Reus C; Camparo P; Compérat E; Phé V
Can J Urol; 2018 Feb; 25(1):9161-9167. PubMed ID: 29524970
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemistry-Based Taxonomical Classification of Bladder Cancer Predicts Response to Neoadjuvant Chemotherapy.
Font A; Domènech M; Benítez R; Rava M; Marqués M; Ramírez JL; Pineda S; Domínguez-Rodríguez S; Gago JL; Badal J; Carrato C; López H; Quer A; Castellano D; Malats N; Real FX
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32635360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
